Manager × security

Solas Capital Management, LLC FENC holdings history

Who else holds this security? →

FENNEC PHARMACEUTICALS INC · CUSIP 31447P100 · CIK 1604867

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Solas Capital Management, LLC reported 1.89M FENC (shares), valued at $20.31M, or 10.88% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
10.88%
Shares
1.89M
1,889,366
Reported value
$20.31M
USD

Shares decreased 23.88%; reported value increased 33.05%, and weight changed +2.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 202610.88%1,889,366SEC filing ↗Filed Aug 14, 2026
Q1 20268.78%2,482,198SEC filing ↗Filed May 15, 2026
Q4 202511.19%2,560,726SEC filing ↗Filed Feb 17, 2026
Q3 202512.50%2,187,902SEC filing ↗Filed Nov 14, 2025
Q2 202510.37%2,232,902SEC filing ↗Filed Aug 14, 2025
Q1 20257.71%2,250,919SEC filing ↗Filed May 15, 2025
Q4 20249.45%2,250,919SEC filing ↗Filed Feb 14, 2025
Q3 20246.75%1,923,536SEC filing ↗Filed Nov 14, 2024
Q2 20244.48%1,340,000SEC filing ↗Filed Aug 14, 2024
Q1 20247.94%1,110,233SEC filing ↗Filed May 15, 2024
Q4 20239.60%1,378,513SEC filing ↗Filed Feb 14, 2024
Q3 20239.07%1,725,567SEC filing ↗Filed Nov 14, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20239.07%1,725,567$12.96MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 14, 2023
Q4 20239.60%1,378,513$15.47MShares decreased 20.11%; reported value increased 19.35%, and weight changed +0.53 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2024
Q1 20247.94%1,110,233$12.35MShares decreased 19.46%; reported value decreased 20.18%, and weight changed -1.66 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20244.48%1,340,000$8.19MShares increased 20.70%; reported value decreased 33.68%, and weight changed -3.46 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20246.75%1,923,536$9.62MShares increased 43.55%; reported value increased 17.47%, and weight changed +2.27 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20249.45%2,250,919$14.23MShares increased 17.02%; reported value increased 47.91%, and weight changed +2.70 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20257.71%2,250,919$13.71MShares unchanged; reported value decreased 3.64%, and weight changed -1.74 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 202510.37%2,232,902$18.53MShares decreased 0.80%; reported value increased 35.20%, and weight changed +2.66 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 202512.50%2,187,902$20.48MShares decreased 2.02%; reported value increased 10.50%, and weight changed +2.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 202511.19%2,560,726$19.72MShares increased 17.04%; reported value decreased 3.72%, and weight changed -1.31 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20268.78%2,482,198$15.27MShares decreased 3.07%; reported value decreased 22.58%, and weight changed -2.41 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 202610.88%1,889,366$20.31MShares decreased 23.88%; reported value increased 33.05%, and weight changed +2.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Solas Capital Management, LLC · FENNEC PHARMACEUTICALS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1604867","quarter":"2026Q2","cusip":"31447P100"}

get_institutional_manager_history
{"cik":"1604867","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.